Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell‐Derived Cardiomyocytes to Zebrafish and Human Hearts
暂无分享,去创建一个
Godfrey L. Smith | Berend J van Meer | Leon G J Tertoolen | Godfrey L Smith | Francis L Burton | Christine L Mummery | Luca Sala | C. Mummery | F. Burton | L. Tertoolen | B. V. van Meer | L. Sala
[1] Godfrey L. Smith,et al. MUSCLEMOTION , 2017, Circulation research.
[2] Adriaan P IJzerman,et al. A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells , 2016, EMBO molecular medicine.
[3] Thomas Eschenhagen,et al. Differentiation of cardiomyocytes and generation of human engineered heart tissue , 2017, Nature Protocols.
[4] Christine L. Mummery,et al. Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease , 2016, Stem cells.
[5] R. Pölönen,et al. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes , 2019, Molecular Biology Reports.
[6] Richard P Davis,et al. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions. , 2016, Methods in molecular biology.
[7] Kelly Rae Chi. Revolution dawning in cardiotoxicity testing , 2013, Nature Reviews Drug Discovery.
[8] Marie C. Phelan. Techniques for Mammalian Cell Tissue Culture , 2001, Current protocols in protein science.
[9] P. Schwartz,et al. Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells , 2018, Arrhythmia & electrophysiology review.
[10] D. Beis,et al. On Zebrafish Disease Models and Matters of the Heart , 2019, Biomedicines.
[11] P. Burridge,et al. Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells , 2015, Current protocols in human genetics.
[12] E. Stanley,et al. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies , 2008, Nature Protocols.